Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals Statistics

Total Valuation

ACXP has a market cap or net worth of $7.86 million. The enterprise value is $1.82 million.

Market Cap	7.86M
Enterprise Value	1.82M

Important Dates

The next confirmed earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ACXP has 1.53 million shares outstanding. The number of shares has increased by 32.56% in one year.

Current Share Class	1.53M
Shares Outstanding	1.53M
Shares Change (YoY)	+32.56%
Shares Change (QoQ)	+18.80%
Owned by Insiders (%)	8.43%
Owned by Institutions (%)	6.17%
Float	1.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.99
P/TBV Ratio	2.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.38

Current Ratio	2.38
Quick Ratio	2.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -285.93% and return on invested capital (ROIC) is -179.56%.

Return on Equity (ROE)	-285.93%
Return on Assets (ROA)	-98.59%
Return on Invested Capital (ROIC)	-179.56%
Return on Capital Employed (ROCE)	-281.70%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.86% in the last 52 weeks. The beta is -1.27, so ACXP's price volatility has been lower than the market average.

Beta (5Y)	-1.27
52-Week Price Change	-85.86%
50-Day Moving Average	5.20
200-Day Moving Average	8.27
Relative Strength Index (RSI)	43.31
Average Volume (20 Days)	168,314

Short Selling Information

The latest short interest is 116,032, so 7.60% of the outstanding shares have been sold short.

Short Interest	116,032
Short Previous Month	63,713
Short % of Shares Out	7.60%
Short % of Float	9.26%
Short Ratio (days to cover)	0.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.05M
Pretax Income	-10.00M
Net Income	-10.00M
EBITDA	n/a
EBIT	-10.05M
Earnings Per Share (EPS)	-$10.37

Balance Sheet

The company has $6.06 million in cash and n/a in debt, giving a net cash position of $6.06 million or $3.97 per share.

Cash & Cash Equivalents	6.06M
Total Debt	n/a
Net Cash	6.06M
Net Cash Per Share	$3.97
Equity (Book Value)	3.57M
Book Value Per Share	2.43
Working Capital	3.57M

Cash Flow

Operating Cash Flow	-8.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.56%
Shareholder Yield	-32.56%
Earnings Yield	-126.80%
FCF Yield	n/a

Analyst Forecast

The average price target for ACXP is $143.67, which is 2,689.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$143.67
Price Target Difference	2,689.71%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 5, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2